Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revatio efficacy in acute vasodilator testing in persistent pulmonary hypertension after successful valve surgery
2009-012005-19Phase 3Completed
- Sponsor
- Vall d'Hebron University Hospital
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sildenafil in pulmonary hypertension (PH), sponsored by Vall d'Hebron University Hospital. Primary endpoints: Acute vasodilator effect compared with nitric oxide and Change in erectile function domain of the IIEF questionnaire at week 6 from baseline. Started Aug 2009; status: completed.
02
Drugs
sildenafil
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on 2009-012005-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012005-19.